Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma.

被引:0
|
作者
Bae, Jooeun [1 ]
Kitayama, Shuichi [1 ]
Herbert, Zach [1 ]
Daheron, Laurence [1 ]
Munshi, Nikhil [1 ]
Kaneko, Shin [1 ]
Ritz, Jerome [1 ]
Anderson, Kenneth [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6347
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Efficacy and safety of BCMA-specific CAR T cell-based therapy in relapsed/refractory multiple myeloma patients with extramedullary disease
    Qi, Yue Kun
    Li, Zhenyu
    Xu, Kailin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S57 - S57
  • [22] Identification of CD8 T-cells specific for cancer-testis antigens in patients with multiple myeloma.
    Goodyear, OC
    Arrazi, J
    Piper, KP
    Khan, N
    Mahendra, P
    Pratt, G
    Moss, P
    BLOOD, 2003, 102 (11) : 366B - 366B
  • [23] Virus Suppressive Activities of CD8+T Cells Correlate with SIV-Specific CD8+T Cell Responses
    Hong, H. S.
    Gillis, J.
    Yu, Y.
    Wong, F. E.
    Johnson, R. P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A88 - A89
  • [24] Efficacy and Safety of BCMA-Specific CAR T Cell-Based Therapy in Relapsed/Refractory Multiple Myeloma Patients with Extramedullary Disease
    Qi, Yuekun
    Qiao, Jianlin
    Li, Zhenyu
    Xu, Kailin
    BLOOD, 2023, 142
  • [25] High-dimensional analysis of the CD8+T cell response in multiple myeloma
    Prazich, Jack
    Jiang, Jenny
    Dhodapkar, Madhav
    Garfall, Alfred
    Adaniya, Sandra
    Adaniya, Sandra
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [26] Characterization of EBV-specific CD8+T cells in Multiple Sclerosis
    Eleonora, Piras
    Giovanna, Borsellino
    Adamo, Diamantini
    Claudio, Gasperini
    Simona, Galgani
    Grazia, Grasso Maria
    Rosella, Mechelli
    Viviana, Annibali
    Francesca, Aloisi
    Giovanni, Ristori
    Marco, Salvetti
    Giorgio, Bernardi
    Diego, Centonze
    Luca, Battistini
    Francesca, Angelini Daniela
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 117 - 118
  • [27] Double autologous stem cell transplantation with CD34 selected cells for multiple myeloma.
    Nedellec, G
    Ceccaldi, B
    Fagot, T
    Souleau, B
    Traulle, C
    Merrer, J
    De Revel, T
    Joussemet, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S137 - S137
  • [28] Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
    Zhang, Xi
    Ng, Yu Yang
    Du, Zhicheng
    Li, Zhendong
    Chen, Can
    Xiao, Lin
    Chng, Wee Joo
    Wang, Shu
    PLOS ONE, 2022, 17 (06):
  • [29] Identification and Validation of Predictive Biomarkers to CD19-and BCMA-Specific CAR T-Cell Responses in Apheresed T-Cells
    Wang, Meng
    Pruteanu, Iulian
    Cohen, Adam D.
    Garfall, Alfred L.
    Milone, Michael C.
    Tian, Lifeng
    Gonzalez, Vanessa E.
    Gill, Saar I.
    Frey, Noelle V.
    Barrett, David M.
    Ruella, Marco
    Lacey, Simon F.
    Svoboda, Jakub
    Chong, Elise A.
    Fraietta, Joseph A.
    Davis, Megan
    Nasta, Sunita
    Levine, Bruce L.
    Siegel, Donald L.
    Maude, Shannon L.
    Schuster, Stephen J.
    Stadtmauer, Edward A.
    Grupp, Stephan A.
    Porter, David L.
    June, Carl H.
    Melenhorst, J. Joseph
    MOLECULAR THERAPY, 2020, 28 (04) : 574 - 575
  • [30] Development of a Human Cytotoxic Myoinjury Model with CD8+T Cells and Muscle Cells Differentiated from Human Induced Pluripotent Stem Cells
    Hasegawa, Hisanori
    Kashima, Soki
    Otsu, Makoto
    Taniguchi, Hideki
    Yasuda, Shinsuke
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 592 - 593